Stanford Pediatric IBD and Celiac Disease Research Program Seed Grants

LETTER OF INTENT DEADLINE: Monday January 10, 2022 - 11:59 PM PST

FULL PROPOSAL DEADLINE (by invitation only): Monday, April 11, 2022 - 11:59 PM PST

The Stanford Pediatric IBD and Celiac Disease Research Awards Program aims to spark innovative and transdisciplinary research and develop new treatments or knowledge to improve the lives of all children with IBD and celiac disease for generations to come.  Through this mechanism we can harness the expertise of investigators already in place across Stanford and pivot their work toward pediatric disease and push research in novel directions to benefit children.  The research awards will help fuel early-stage, high-risk, high-reward projects not yet ready for NIH or other government funding.  

A multi-PI approach is strongly encouraged for this initiative where at least two of the lead investigators are from different disciplines. Collaborations between basic or data scientists and physician scientists are particularly encouraged. Single-PI applications will be considered if the scientific rationale is compelling. Proposals should demonstrate a clear potential for the research to generate robust preliminary data for future applications to external funding agencies.  

The awards will provide up to 2 years of funding to support a wide range of scientific approaches with the potential to advance our understanding of pediatric IBD and celiac disease including but not limited to the following areas: 

Basic and translational research of disease mechanisms, therapeutic strategies, or treatment response in the areas of epithelial biology, microbiology, immunology, enteric nervous system.

Development of novel technologies to advance IBD research, diagnosis or evaluation, disease monitoring, treatments, or disease/response prediction (biomedical or chemical engineering, computer science).

Clinical research of novel treatment strategies or impactful health services, epidemiologic, outcomes, or health care disparities research.

Computational or systems biological approaches to advance understanding of disease mechanisms, treatment targets, or treatment response.

Jump to Page

Key Dates

Action Date
LOI Deadline January 10, 2022
Full Proposal (by invitation) Deadline April 11, 2022
Notification of Awards June 2022
Award Start Date July 1, 2022

Term of Award

All awardees are limited to a single award of up to 2 years.

Forms for Applicants

General Eligibility

Eligible applicants must be Stanford faculty holding Clinician Educator (CE), University Tenure Line (UTL), Research (NTL-Research), or University Medical Line (UML) positions for the duration of the award.  Visiting scholars are not eligible to serve as PI or Co-PI.  They may serve as collaborators or sub-investigators.  Applications may include co-investigators from other research organizations.

Institutional representative: not applicable. These programs are internal Stanford funding opportunities. Please do not submit your proposal through your institutional official for approval. You may submit your proposal directly to MCHRI via their online application link. PI Waivers are not required. 


Funding Amount

Up to $100,000 / year for up to two years. Total award of $200,000. Should there be a carryforward balance of greater than twenty-five percent, the funds transfer will be held at the discretion of MCHRI until the balance has been expended.

Funds cannot be used for student tuition or fees, computer equipment, office supplies, ITCC communications, journal subscriptions, membership dues, poster presentations, abstract submissions, or any indirect research costs.

*If a substantial portion of the budget will be used to support a post-doctoral fellow, please consider the Stanford Pediatric Inflammatory Bowel (IBD) and Celiac Disease Post-doctoral Fellow Awards Program funding opportunity.  

Assessment Criteria

Letters of intent and full proposals will be reviewed by the Stanford Pediatric IBD and Celiac Disease Research Awards Program Scientific Advisory Board (SAB) and external peer reviewers.  Assessments will be based on the significance, innovation and approach of the proposed research; research environment and investigator team; relevance and potential impact of the research on pediatric IBD and celiac disease.

Funding Rate

YEAR LOI Applicants Invited Full Proposal Applicants Grants Awarded  Funding Rate Total Awarded
FY 20 20 14 5 25% $1,000,000

Policy Updates

Visit the Policy Updates page for more information.


Visit Frequently Asked Questions for more information.


Please contact Kim Stern at or 650-724-0279.